Nuvasive 

$39.75
3
-$0.91-2.24% Thursday 20:00

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
2.07B
市盈率
-107.61
股息率
-
股息
-

财报

7Nov预期
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
0.39
0.45
0.5
0.56
预期EPS
0.5384
实际EPS
不适用

财务

3.36%利润率
有盈利
2017
2018
2019
2020
2021
2022
1.2B营收
40.41M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 NUVA 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Show more...
首席执行官
J. Christopher Barry
员工
2900
国家
美国
ISIN
US6707041058
WKN
000A0CAYR

上市

0 Comments

分享你的想法

FAQ

Nuvasive 今天的股价是多少?
NUVA 当前价格为 $39.75 USD,在过去 24 小时内下跌了 -2.24%。在图表上更密切关注 Nuvasive 股票的表现。
Nuvasive 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Nuvasive 的股票以代码 NUVA 进行交易。
Nuvasive 的市值是多少?
今天 Nuvasive 的市值为 2.07B
Nuvasive 去年的营收是多少?
Nuvasive 去年的营收为 1.2BUSD。
Nuvasive 去年的净利润是多少?
NUVA 去年的净收益为 40.41MUSD。
Nuvasive 有多少名员工?
截至四月 13, 2026,公司共有2,900名员工。
Nuvasive 属于哪个行业?
Nuvasive从事于制造业行业。
Nuvasive 何时完成拆股?
Nuvasive 最近没有进行任何拆股。
Nuvasive 的总部在哪里?
Nuvasive 的总部位于 美国 的 San Diego。